We are live on
!
Find out more
VI
Vestcor Inc Portfolio holdings
AUM
$3.63B
1-Year Est. Return
21.49%
This Fund
S&P 500
This Quarter
Est. Return
+8.67%
1 Year Est. Return
+21.49%
3 Year Est. Return
+77.59%
5 Year Est. Return
+109.03%
10 Year Est. Return
–
AUM
$3.31B
AUM Growth
+$335M
(+11%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
4.73%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
1,258
New
99
Increased
403
Reduced
396
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VeriSign
VRSN
|
+$11.9M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$9.72M |
| 3 |
SKX
Skechers
SKX
|
+$9.47M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$9.4M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$8.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$16.9M |
| 2 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$12.5M |
| 3 |
Hershey
HSY
|
+$8.33M |
| 4 |
Sprouts Farmers Market
SFM
|
+$8.12M |
| 5 |
Marathon Petroleum
MPC
|
+$7.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.22% |
| 2 | Financials | 10.93% |
| 3 | Healthcare | 10.69% |
| 4 | Consumer Staples | 10.68% |
| 5 | Consumer Discretionary | 8.56% |
Similar funds
JFG
GCM
ACM
APP
SCM
OCM
WB
SL
Vestcor Inc's Q2 2025 Portfolio in Review
As of Q2 2025, Vestcor Inc held 1,258 positions worth $3.31B, up 11% from $2.97B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Vestcor Inc deployed $156M of net new capital in Q2 2025, opening 99 new positions and adding to 403 existing holdings. Its largest new stake was Skechers: 165,000 shares worth $10.4M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Hershey, an estimated $8.33M trimmed.
- Vestcor Inc's largest Q2 2025 buy was Skechers: 165,000 shares worth $10.4M.
- Vestcor Inc added most to VeriSign in Q2 2025, an estimated $11.9M increase.
- Vestcor Inc's biggest Q2 2025 reduction was Hershey, cutting an estimated $8.33M.
- Vestcor Inc fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $16.9M.
- Vestcor Inc's ten largest holdings make up 17% of its $3.31B portfolio in Q2 2025.
- Vestcor Inc opened 99 new positions and closed 104 in Q2 2025.
- Vestcor Inc's portfolio value rose 11% quarter-over-quarter to $3.31B.
Based on Vestcor Inc's 13F filing for Q2 2025, filed 8 Aug 2025.